Announcements Trials
Browse Landscape

Phase

Phase 3 7Phase NA 2Phase 4 2Phase 1/2 1Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 2Venous Thrombosis 1Venous Thromboembolism 1Upper Extremity Deep Vein Thrombosis 1Recurrence 1Lung Neoplasms 1Hemorrhage 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Dexamethasone 8Oxycodone 6Epoetin Alfa 5Propofol 4Palonosetron 4Meropenem 4Zoledronic Acid 3Vancomycin 3Sevoflurane 3Ondansetron 3Naloxone 3Everolimus 3Ciprofloxacin 3Cholecalciferol 3Ceftazidime 3Cefepime 3Calcium Dobesilate 3Bevacizumab 3Aspirin 3Aprepitant 3peginterferon alfa-2a 2edoxaban 2apixaban 2apatinib 2Vitamin B 12 2Vincristine 2Tobacco Use Cessation Devices 2Teicoplanin 2Tablets 2Surgical Procedures, Operative 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Neoplasms × Rivaroxaban × Clear all
NCT04256525 2020-06-30

Prophylactic Anticoagulation for Catheter-related Thrombosis

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 4 Unknown
1,640 enrolled
Tumor-Agnostic

Neoplasms

NCT01708850 2016-09-08

Study in Cancer Patients With Central Line Associated Clots in the Upper Extremity Treated With Rivaroxaban (Catheter 2)

London Health Sciences Centre

Phase 4 Completed
70 enrolled

Neoplasms, Upper Extremity Deep Vein Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡